Crowley R W, Secchiero P, Zella D, Cara A, Gallo R C, Lusso P
Laboratory of Tumor Cell Biology, National Cancer Institute, Bethesda, MD 20894, USA.
J Immunol. 1996 Mar 1;156(5):2004-8.
Human herpesvirus 7 (HHV-7) uses CD4 as a cellular membrane receptor and thereby interferes with infection of CD4+ T cells by HIV-1. We studied the interactions between HHV-7 and a macrophage-tropic HIV-1 isolate (HIV-1BaL) in terminally differentiated human peripheral blood monocyte-derived macrophages, another critical target for infection by HIV-1 in vivo. Exposure of macrophages to HHV-7 alone yielded no signs of virus replication or cytopathic effects. Nevertheless, when macrophages were pre-exposed to either live or UV-inactivated HHV-7 and subsequently infected with HIV-1BaL, a significant dose-dependent inhibition of HIV-1 replication was documented. At day 7 postinfection, the average level of HIV-1 p24 Ag in cultures from five different donors was reduced by 91.7 +/- 8.3% by pretreatment with live HHV-7 and by 91.8 +/- 8.2% by pretreatment with UV-inactivated HHV-7. Moreover, the synthesis of HIV-1 proviral DNA in macrophages pretreated with HHV-7 was completely inhibited during the early stages after infection, suggesting that HHV-7 blocks HIV-1 at the level of interaction with the CD4 receptor. Consistent with this concept, both macrophage and CD4+ T cell cultures with pre-established HIV-1 infection were not susceptible to inhibitory effects of HHV-7. The proliferative response of PBMC to mitogens was only marginally inhibited by exposure to HHV-7 before mitogen stimulation, indicating that the inhibition of HIV-1 infection was not due to a negative effect on cell proliferation. These data demonstrate that HHV-7 is a powerful inhibitor of HIV-1 infection in cells of the mononuclear phagocytic lineage, despite its inability to replicate actively in such cells.
人类疱疹病毒7型(HHV-7)将CD4作为细胞膜受体,从而干扰HIV-1对CD4+T细胞的感染。我们研究了HHV-7与一株嗜巨噬细胞性HIV-1分离株(HIV-1BaL)在终末分化的人外周血单核细胞来源的巨噬细胞中的相互作用,巨噬细胞是HIV-1在体内感染的另一个关键靶细胞。单独将巨噬细胞暴露于HHV-7未产生病毒复制迹象或细胞病变效应。然而,当巨噬细胞预先暴露于活的或紫外线灭活的HHV-7,随后感染HIV-1BaL时,发现HIV-1复制受到显著的剂量依赖性抑制。在感染后第7天,来自5个不同供体的培养物中HIV-1 p24抗原的平均水平,经活的HHV-7预处理降低了91.7±8.3%,经紫外线灭活的HHV-7预处理降低了91.8±8.2%。此外,在感染后的早期阶段,用HHV-7预处理的巨噬细胞中HIV-1前病毒DNA的合成被完全抑制,这表明HHV-7在与CD4受体相互作用的水平上阻断了HIV-1。与此概念一致的是,预先建立HIV-1感染的巨噬细胞和CD4+T细胞培养物对HHV-7的抑制作用均不敏感。在有丝分裂原刺激前暴露于HHV-7,PBMC对有丝分裂原的增殖反应仅受到轻微抑制,这表明对HIV-1感染的抑制并非由于对细胞增殖的负面影响。这些数据表明,HHV-7是单核吞噬细胞系细胞中HIV-1感染的强力抑制剂,尽管它无法在此类细胞中活跃复制。